Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kawasaki syndrome

H C Meissner1, D Y Leung

  • 1Department of Pediatrics, Floating Hospital for Children, New England Medical Center, Boston, MA 02111-1526, USA.

Current Opinion in Rheumatology
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus guidelines for interventional cardiology services delivery during covid-19 pandemic in Australia and new Zealand.

Heart, lung & circulation·2020
Same author

Altered composition of epidermal lipids correlates with Staphylococcus aureus colonization status in atopic dermatitis.

The British journal of dermatology·2017
Same author

Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis. Pediatrics. 2014;134(5):e1474-e1502.

Pediatrics·2015
Same author

Induction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2010
Same author

Tissue Doppler echocardiography.

Minerva cardioangiologica·2010
Same author

Advanced applications of 3-dimensional echocardiography.

Minerva cardioangiologica·2009
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Kawasaki syndrome may be triggered by superantigens, supported by immunologic changes and bacterial toxins. Standard treatment with intravenous gamma globulin and aspirin effectively prevents coronary artery abnormalities in most children.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Cardiology

Background:

  • Kawasaki syndrome etiology remains unclear.
  • Emerging evidence suggests a superantigen-mediated immune response.
  • Associations with toxin-producing bacteria have been observed.

Purpose of the Study:

  • To review the evidence supporting superantigen involvement in Kawasaki syndrome.
  • To discuss the immunologic characteristics of the acute illness.
  • To highlight current therapeutic standards and long-term outcomes.

Main Methods:

  • Review of immunologic findings in acute Kawasaki syndrome.
  • Analysis of associations with bacterial toxins.
  • Evaluation of treatment efficacy and long-term follow-up data.

Related Experiment Videos

Main Results:

  • Immunologic changes suggest a superantigen-driven process.
  • Toxin-producing bacteria in the pharynx and GI tract are implicated.
  • Intravenous gamma globulin and high-dose aspirin are effective standard therapies.

Conclusions:

  • Kawasaki syndrome is likely a superantigen-mediated illness.
  • Current treatments significantly reduce the risk of coronary artery abnormalities.
  • Long-term follow-up confirms the effectiveness of standard care.